HealthMore in Health→
Eli Lilly Pushes Employers to Cover GLP-1 Drugs
Key Takeaways
- Eli Lilly offers employers outcome-based contracts for GLP-1 drug coverage
- Over 40% of US adults meet clinical criteria for obesity treatment
- Program includes negotiated pricing tiers and workplace wellness integration
- Competitive move against Novo Nordisk's dominant Ozempic and Wegovy
DE
DT Editorial Team··3 min read·via endpoints.news